SCHEMBL7983608

SCHEMBL7983608

CCCCCCNc1nc2ccccc2n2cncc12

nearest known ligand 0.81

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.81
TOP2A P11388 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983684 0.99 LCK (0.83) LCKTOP2A
SCHEMBL7969596 0.90 LCK (1.00) LCKTOP2A
SCHEMBL7981952 0.84 LCK (0.71) LCK
SCHEMBL7981429 0.81 LCK (0.74) LCK
SCHEMBL7987863 0.79 LCK (0.65) LCK
SCHEMBL7983557 0.78 LCK (0.70) LCK
SCHEMBL7980641 0.76 LCK (0.67) LCK
SCHEMBL7983552 0.76 LCK (0.67) LCK
SCHEMBL7980293 0.76 LCK (0.66) LCK
SCHEMBL7983198 0.75 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed